Pediatric Vaccines Market, Company Sales and Forecast - Global Analysis
The growing awareness about the importance of child healthcare and well-being is driving the market for pediatric vaccines globally. Pediatric vaccine continues to be one of the booming segment for the pharmaceutical companies. Pediatric vaccines are used in the prevention of numerous diseases, such as Hepatitis- A and -B. Measles, Influenza, Polio, Tetanus, and Diphtheria. Increasing government and non-government funding for development of vaccine is the major driver for the pediatric vaccine market. The rising incidence of diseases such as influenza, hepatitis and HPV has also fueled the demand for the global pediatric vaccines market. The vaccines industry also faces hindrances such as vaccine safety, shortages and delays, vaccine development time line as well as entry barriers for new manufacturers.
Pediatric Vaccines Market - Disease Wise Analysis
The pneumococcal vaccines accounts for maximum share of the pediatric vaccines market. The DTaP vaccines were the second most popular segment in the year 2015. It is competing closely with MMRV vaccines which controlled XX% share of the pediatric vaccines market in 2015. The rotavirus and influenza vaccines stands at fourth and fifth spots respectively in 2015. While vaccines for Polio, meningococcal and HPV are also gaining ground in pediatric vaccines market landscape.
Pediatric Vaccines Market - Company Analysis
Pfizer is the leading player in the pediatric vaccines market being followed by GSK at the second spot. Merck grabbed the third spot in the Global pediatric vaccines landscape as it provides a wide array of vaccines for various diseases. Sanofi Pasteur and Medimmune stands at the fourth and fifth position respectively in the pediatric vaccines market, while, bioCSl captures least share of the global pediatric vaccines market.
Pediatric Vaccines Market - Disease Wise Company Sales Analysis
GSK and Sanofi Pasteur generates maximum pediatric vaccines revenue from DTaP vaccines. The MMRV vaccines accounts for maximum share of the total Merck pediatric vaccines sales, while, Pfizer’s main source of pediatric vaccines sales revenue is the pneumococcal vaccines.
Sanofi Pasteur is the dominant player in the DTaP, influenza and meningococcal pediatric vaccines landscape, while in the hepatitis vaccines market, GSK is at the forefront and is expected to maintain its dominancy over a longer period of time. Pfizer is the clear leader in pneumococcal vaccines market. Merck is the leading player in the MMRV and rotavirus vaccines market.
Pediatric Vaccines Market - Regional Distribution
On a regional basis the United States comprises the single largest market for pediatric vaccines being closely followed by Europe. Japan’s pediatric vaccines market share is expected to remain flat during the forecasting period. China accounts for XX% share of the global pediatric vaccines market in 2015. South America and India are competing closely with each other to grab maximum share of the pediatric vaccines market pie.
iGATE RESEARCH report entitled “Pediatric Vaccines Market, Company Sales and Forecast - Global Analysis” provides a comprehensive analysis of the fast-evolving high growth vaccines market. This 205 Page report with 116 Figures and 6 Tables has been analyzed from 7 viewpoints:
1. Global Pediatric Vaccines Market - Disease Wise Analysis to 2021
2. Global Pediatric Vaccines Market - Company Sales Analysis and Strategic Alliances
3. Global Pediatric Vaccines - Disease Wise Company Sales and Forecast to 2021
4. Pediatric Vaccines Disease Wise Market - Company Share and Forecast
5. Global Pediatric Vaccines Market - Regional Distribution to 2021
6. Major Vaccines Related Acquisitions (2005-2015)
7. Pediatric Vaccines Market - Driving Factors and Challenges
Global Pediatric Vaccines Market - Disease Wise Analysis to 2021 (10 Disease Analysed)
1. DTaP
2. Polio
3. Hepatitis
4. Influenza
5. HPV
6. Pneumococcal
7. Meningococcal
8. MMRV
9. Rotavirus
10. Tdap
Global Pediatric Vaccines Market - Company Analysis to 2021 (7 Company Analysed)
1. GlaxoSmithKline
2. Sanofi Pasteur
3. Merck
4. Novartis
5. Pfizer
6. bioCSL
7. Medimmune
Global Pediatric Vaccines Market - Geographical Distribution to 2021 (8 Region Analysed)
1. United States
2. North America/Caribbean
3. South America
4. Europe
5. Japan
6. India
7. China
8. Rest of the World
Data Sources
iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.
Research Methodologies
Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.
Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.
Pediatric Vaccines Market - Disease Wise Analysis
The pneumococcal vaccines accounts for maximum share of the pediatric vaccines market. The DTaP vaccines were the second most popular segment in the year 2015. It is competing closely with MMRV vaccines which controlled XX% share of the pediatric vaccines market in 2015. The rotavirus and influenza vaccines stands at fourth and fifth spots respectively in 2015. While vaccines for Polio, meningococcal and HPV are also gaining ground in pediatric vaccines market landscape.
Pediatric Vaccines Market - Company Analysis
Pfizer is the leading player in the pediatric vaccines market being followed by GSK at the second spot. Merck grabbed the third spot in the Global pediatric vaccines landscape as it provides a wide array of vaccines for various diseases. Sanofi Pasteur and Medimmune stands at the fourth and fifth position respectively in the pediatric vaccines market, while, bioCSl captures least share of the global pediatric vaccines market.
Pediatric Vaccines Market - Disease Wise Company Sales Analysis
GSK and Sanofi Pasteur generates maximum pediatric vaccines revenue from DTaP vaccines. The MMRV vaccines accounts for maximum share of the total Merck pediatric vaccines sales, while, Pfizer’s main source of pediatric vaccines sales revenue is the pneumococcal vaccines.
Sanofi Pasteur is the dominant player in the DTaP, influenza and meningococcal pediatric vaccines landscape, while in the hepatitis vaccines market, GSK is at the forefront and is expected to maintain its dominancy over a longer period of time. Pfizer is the clear leader in pneumococcal vaccines market. Merck is the leading player in the MMRV and rotavirus vaccines market.
Pediatric Vaccines Market - Regional Distribution
On a regional basis the United States comprises the single largest market for pediatric vaccines being closely followed by Europe. Japan’s pediatric vaccines market share is expected to remain flat during the forecasting period. China accounts for XX% share of the global pediatric vaccines market in 2015. South America and India are competing closely with each other to grab maximum share of the pediatric vaccines market pie.
iGATE RESEARCH report entitled “Pediatric Vaccines Market, Company Sales and Forecast - Global Analysis” provides a comprehensive analysis of the fast-evolving high growth vaccines market. This 205 Page report with 116 Figures and 6 Tables has been analyzed from 7 viewpoints:
1. Global Pediatric Vaccines Market - Disease Wise Analysis to 2021
2. Global Pediatric Vaccines Market - Company Sales Analysis and Strategic Alliances
3. Global Pediatric Vaccines - Disease Wise Company Sales and Forecast to 2021
4. Pediatric Vaccines Disease Wise Market - Company Share and Forecast
5. Global Pediatric Vaccines Market - Regional Distribution to 2021
6. Major Vaccines Related Acquisitions (2005-2015)
7. Pediatric Vaccines Market - Driving Factors and Challenges
Global Pediatric Vaccines Market - Disease Wise Analysis to 2021 (10 Disease Analysed)
1. DTaP
2. Polio
3. Hepatitis
4. Influenza
5. HPV
6. Pneumococcal
7. Meningococcal
8. MMRV
9. Rotavirus
10. Tdap
Global Pediatric Vaccines Market - Company Analysis to 2021 (7 Company Analysed)
1. GlaxoSmithKline
2. Sanofi Pasteur
3. Merck
4. Novartis
5. Pfizer
6. bioCSL
7. Medimmune
Global Pediatric Vaccines Market - Geographical Distribution to 2021 (8 Region Analysed)
1. United States
2. North America/Caribbean
3. South America
4. Europe
5. Japan
6. India
7. China
8. Rest of the World
Data Sources
iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.
Research Methodologies
Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.
Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.
1. EXECUTIVE SUMMARY
2. GLOBAL - PEDIATRIC VACCINES MARKET AND FORECAST (2010 - 2021)
3. GLOBAL - PEDIATRIC VACCINES MARKET SHARE AND FORECAST (2010 - 2021)
3.1 Global Pediatric Vaccines - Disease Wise Market Share and Forecast
3.2 Global Pediatric Vaccines - Company Wise Market Share and Forecast
3.3 Companies Pediatric Vaccines - Disease Wise Sales Share and Forecast
3.3.1 GlaxoSmithKline (GSK) - Pediatric Vaccines Sales Share and Forecast
3.3.2 Sanofi Pasteur - Pediatric Vaccines Sales Share and Forecast
3.3.3 Merck - Pediatric Vaccines Sales Share and Forecast
3.3.4 Pfizer - Pediatric Vaccines Sales Share and Forecast
3.4 Pediatric Vaccines Disease Wise Market - Company Share and Forecast
3.4.1 DTaP Pediatric Vaccines - Company Market Share and Forecast
3.4.2 Hepatitis Pediatric Vaccines - Company Market Share and Forecast
3.4.3 Meningococcal Pediatric Vaccines - Company Market Share and Forecast
3.4.4 Pneumococcal Pediatric Vaccines - Company Market Share and Forecast
3.4.5 Rotavirus Pediatric Vaccines - Company Market Share and Forecast
3.4.6 Tdap Pediatric Vaccines - Company Market Share and Forecast
3.4.7 Influenza Pediatric Vaccines - Company Market Share and Forecast
3.5 Global Pediatric Vaccines Market - Region Wise Share and Forecast
4. GLOBAL PEDIATRIC VACCINES MARKET - DISEASE WISE ANALYSIS
4.1 Diphtheria, Tetanus, Acellular, Pertussis (DTaP) - Pediatric Vaccines Market and Forecast (2006 - 2021)
4.2 Polio - Vaccines Market and Forecast (2006 - 2021)
4.3 Hepatitis - Pediatric Vaccines Market and Forecast (2007 - 2021)
4.4 Influenza - Pediatric Vaccines Market and Forecast (2010 - 2021)
4.5 HPV - Pediatric Vaccines Market and Forecast (2007 - 2021)
4.6 Pneumococcal - Pediatric Vaccines Market and Forecast (2010 - 2021)
4.7 Meningococcal - Pediatric Vaccines Market and Forecast (2010 - 2021)
4.8 Measles, Mumps, Rubella and Varicella (MMRV) - Pediatric Vaccines Market and Forecast (2007 - 2021)
4.9 Rotavirus - Pediatric Vaccines Market and Forecast (2006 - 2021)
4.10 Tdap - Pediatric Vaccines Market and Forecast (2010 - 2021)
5. GLOBAL PEDIATRIC VACCINES MARKET - COMPANY ANALYSIS AND STRATEGIC ALLIANCES
5.1 GlaxoSmithKline
5.1.1 GlaxoSmithKline (GSK) - Pediatric Vaccines Sales and Forecast (2010 - 2021)
5.1.2 Strategic Alliances of GlaxoSmithKline (GSK)
5.2 Sanofi Pasteur
5.2.1 Sanofi Pasteur - Pediatric Vaccines Sales and Forecast (2010 - 2021)
5.2.2 Strategic Alliances of Sanofi Pasteur
5.3 Merck
5.3.1 Merck - Pediatric Vaccines Sales and Forecast (2007 - 2021)
5.3.2 Strategic Alliances of Merck
5.4 Novartis
5.4.1 Novartis - Pediatric Vaccines Sales (2010 - 2014)
5.4.2 Strategic Alliances of Novartis
5.5 Pfizer
5.5.1 Pfizer - Pediatric Vaccines Sales and Forecast (2010 - 2021)
5.5.2 Strategic Alliances of Pfizer
5.6 bioCSL (Now Seqirus)
5.6.1 bioCSL - Pediatric Vaccines Sales and Forecast (2010 - 2021)
5.6.2 Strategic Alliances of bioCSL
5.7 Medimmune (Subsidiary of AstraZeneca)
5.7.1 Medimmune - Pediatric Vaccines Sales and Forecast (2007 - 2021)
5.7.2 Strategic Alliances of Medimmune
6. GLOBAL PEDIATRIC VACCINES - DISEASE WISE COMPANY SALES AND FORECAST
6.1 GlaxoSmithKline (GSK) - Pediatric Vaccines Sales and Forecast (2010 - 2021)
6.1.1 GlaxoSmithKline (GSK) - DTaP Pediatric Vaccines Sales and Forecast
6.1.2 GlaxoSmithKline (GSK) - Hepatitis Pediatric Vaccines Sales and Forecast
6.1.3 GlaxoSmithKline (GSK) - Meningococcal Pediatric Vaccines Sales and Forecast
6.1.4 GlaxoSmithKline (GSK) - Rotavirus Pediatric Vaccines Sales and Forecast
6.1.5 GlaxoSmithKline (GSK) - Tdap Pediatric Vaccines Sales and Forecast
6.1.6 GlaxoSmithKline (GSK) - Influenza Pediatric Vaccines Sales and Forecast
6.2 Sanofi Pasteur - Pediatric Vaccines Sales and Forecast (2010 - 2021)
6.2.1 Sanofi Pasteur - DTaP Pediatric Vaccines Sales and Forecast
6.2.2 Sanofi Pasteur - Meningococcal Pediatric Vaccines Sales and Forecast
6.2.3 Sanofi Pasteur - Tdap Pediatric Vaccines Sales and Forecast
6.2.4 Sanofi Pasteur - Influenza Pediatric Vaccines Sales and Forecast
6.3 Merck - Pediatric Vaccines Sales and Forecast (2007 - 2021)
6.3.1 Merck - Hepatitis Pediatric Vaccines Sales and Forecast
6.3.2 Merck - HPV Pediatric Vaccines Sales and Forecast
6.3.3 Merck - MMRV Pediatric Vaccines Sales and Forecast
6.3.4 Merck - Pneumococcal Pediatric Vaccines Sales and Forecast
6.3.5 Merck - Rotavirus Pediatric Vaccines Sales and Forecast
6.4 Pfizer - Pediatric Vaccines Sales and Forecast (2010 - 2021)
6.4.1 Pfizer - Pneumococcal Pediatric Vaccines Sales and Forecast
6.4.2 Pfizer - Meningococcal Pediatric Vaccines Sales and Forecast
6.5 Novartis - Pediatric Vaccines Sales (2010 - 2014)
6.5.1 Novartis - Influenza Pediatric Vaccines Sales
6.6 bioCSL (Now Seqirus) - Pediatric Vaccines Sales and Forecast (2010 - 2021)
6.6.1 bioCSL - Influenza Pediatric Vaccines Sales and Forecast
6.7 Medimmune (Subsidiary of AstraZeneca) - Pediatric Vaccines Sales and Forecast (2007 - 2021)
6.7.1 Medimmune - Influenza Pediatric Vaccines Sales and Forecast
7. GLOBAL PEDIATRIC VACCINES MARKET - REGIONAL DISTRIBUTION (2010 - 2021)
7.1 United States - Pediatric Vaccines Market and Forecast
7.2 North America/Caribbean - Pediatric Vaccines Market and Forecast
7.3 South America - Pediatric Vaccines Market and Forecast
7.4 Europe - Pediatric Vaccines Market and Forecast
7.5 Japan - Pediatric Vaccines Market and Forecast
7.6 India - Pediatric Vaccines Market and Forecast
7.7 China - Pediatric Vaccines Market and Forecast
7.8 Rest of the World (ROW) - Pediatric Vaccines Market and Forecast
8. MAJOR VACCINES RELATED ACQUISITIONS (2005-2015)
9. PEDIATRIC VACCINES MARKET - DRIVING FACTORS
9.1 GAVI Model Fuelling Vaccine Manufacturers
9.1.1 The Partnership Model
9.1.2 The Business Model
9.2 Global Immunization Vision and Strategy (GIVS)
9.3 Growing Vaccine Availability in United States
9.4 The Vaccine Injury Compensation Program
9.5 The Vaccine Safety Data link Project
9.6 Transformation of Vaccine Technologies
9.7 Global Vaccine Action Plan by WHO (2011 - 2020)
9.8 Continuous Focus on Effective Communication Strategies
10. PEDIATRIC VACCINES MARKET - CHALLENGES
10.1 Hurdles to Optimal use of Licensed Vaccines
10.1.1 Technical Obstacles
10.1.2 Economic obstacles
10.1.3 Cultural Obstacles
10.2 Shortening the Timeline for Vaccine Development
10.3 Complexity of Vaccine Development and Approval System Thwarts Product Development
10.3.1 Legal Obstacles
10.3.2 General Technical Barriers
10.3.3 Economic Barriers
10.3.4 Regulatory Barriers
10.4 Refusal/Resistance to Vaccination
10.5 Vaccine Adverse Event Reporting System
10.6 Vaccine Shortages and Delays
10.7 Obstacles in Vaccine Research and Development
10.8 Barriers to New Entrants in the Vaccines Market
2. GLOBAL - PEDIATRIC VACCINES MARKET AND FORECAST (2010 - 2021)
3. GLOBAL - PEDIATRIC VACCINES MARKET SHARE AND FORECAST (2010 - 2021)
3.1 Global Pediatric Vaccines - Disease Wise Market Share and Forecast
3.2 Global Pediatric Vaccines - Company Wise Market Share and Forecast
3.3 Companies Pediatric Vaccines - Disease Wise Sales Share and Forecast
3.3.1 GlaxoSmithKline (GSK) - Pediatric Vaccines Sales Share and Forecast
3.3.2 Sanofi Pasteur - Pediatric Vaccines Sales Share and Forecast
3.3.3 Merck - Pediatric Vaccines Sales Share and Forecast
3.3.4 Pfizer - Pediatric Vaccines Sales Share and Forecast
3.4 Pediatric Vaccines Disease Wise Market - Company Share and Forecast
3.4.1 DTaP Pediatric Vaccines - Company Market Share and Forecast
3.4.2 Hepatitis Pediatric Vaccines - Company Market Share and Forecast
3.4.3 Meningococcal Pediatric Vaccines - Company Market Share and Forecast
3.4.4 Pneumococcal Pediatric Vaccines - Company Market Share and Forecast
3.4.5 Rotavirus Pediatric Vaccines - Company Market Share and Forecast
3.4.6 Tdap Pediatric Vaccines - Company Market Share and Forecast
3.4.7 Influenza Pediatric Vaccines - Company Market Share and Forecast
3.5 Global Pediatric Vaccines Market - Region Wise Share and Forecast
4. GLOBAL PEDIATRIC VACCINES MARKET - DISEASE WISE ANALYSIS
4.1 Diphtheria, Tetanus, Acellular, Pertussis (DTaP) - Pediatric Vaccines Market and Forecast (2006 - 2021)
4.2 Polio - Vaccines Market and Forecast (2006 - 2021)
4.3 Hepatitis - Pediatric Vaccines Market and Forecast (2007 - 2021)
4.4 Influenza - Pediatric Vaccines Market and Forecast (2010 - 2021)
4.5 HPV - Pediatric Vaccines Market and Forecast (2007 - 2021)
4.6 Pneumococcal - Pediatric Vaccines Market and Forecast (2010 - 2021)
4.7 Meningococcal - Pediatric Vaccines Market and Forecast (2010 - 2021)
4.8 Measles, Mumps, Rubella and Varicella (MMRV) - Pediatric Vaccines Market and Forecast (2007 - 2021)
4.9 Rotavirus - Pediatric Vaccines Market and Forecast (2006 - 2021)
4.10 Tdap - Pediatric Vaccines Market and Forecast (2010 - 2021)
5. GLOBAL PEDIATRIC VACCINES MARKET - COMPANY ANALYSIS AND STRATEGIC ALLIANCES
5.1 GlaxoSmithKline
5.1.1 GlaxoSmithKline (GSK) - Pediatric Vaccines Sales and Forecast (2010 - 2021)
5.1.2 Strategic Alliances of GlaxoSmithKline (GSK)
5.2 Sanofi Pasteur
5.2.1 Sanofi Pasteur - Pediatric Vaccines Sales and Forecast (2010 - 2021)
5.2.2 Strategic Alliances of Sanofi Pasteur
5.3 Merck
5.3.1 Merck - Pediatric Vaccines Sales and Forecast (2007 - 2021)
5.3.2 Strategic Alliances of Merck
5.4 Novartis
5.4.1 Novartis - Pediatric Vaccines Sales (2010 - 2014)
5.4.2 Strategic Alliances of Novartis
5.5 Pfizer
5.5.1 Pfizer - Pediatric Vaccines Sales and Forecast (2010 - 2021)
5.5.2 Strategic Alliances of Pfizer
5.6 bioCSL (Now Seqirus)
5.6.1 bioCSL - Pediatric Vaccines Sales and Forecast (2010 - 2021)
5.6.2 Strategic Alliances of bioCSL
5.7 Medimmune (Subsidiary of AstraZeneca)
5.7.1 Medimmune - Pediatric Vaccines Sales and Forecast (2007 - 2021)
5.7.2 Strategic Alliances of Medimmune
6. GLOBAL PEDIATRIC VACCINES - DISEASE WISE COMPANY SALES AND FORECAST
6.1 GlaxoSmithKline (GSK) - Pediatric Vaccines Sales and Forecast (2010 - 2021)
6.1.1 GlaxoSmithKline (GSK) - DTaP Pediatric Vaccines Sales and Forecast
6.1.2 GlaxoSmithKline (GSK) - Hepatitis Pediatric Vaccines Sales and Forecast
6.1.3 GlaxoSmithKline (GSK) - Meningococcal Pediatric Vaccines Sales and Forecast
6.1.4 GlaxoSmithKline (GSK) - Rotavirus Pediatric Vaccines Sales and Forecast
6.1.5 GlaxoSmithKline (GSK) - Tdap Pediatric Vaccines Sales and Forecast
6.1.6 GlaxoSmithKline (GSK) - Influenza Pediatric Vaccines Sales and Forecast
6.2 Sanofi Pasteur - Pediatric Vaccines Sales and Forecast (2010 - 2021)
6.2.1 Sanofi Pasteur - DTaP Pediatric Vaccines Sales and Forecast
6.2.2 Sanofi Pasteur - Meningococcal Pediatric Vaccines Sales and Forecast
6.2.3 Sanofi Pasteur - Tdap Pediatric Vaccines Sales and Forecast
6.2.4 Sanofi Pasteur - Influenza Pediatric Vaccines Sales and Forecast
6.3 Merck - Pediatric Vaccines Sales and Forecast (2007 - 2021)
6.3.1 Merck - Hepatitis Pediatric Vaccines Sales and Forecast
6.3.2 Merck - HPV Pediatric Vaccines Sales and Forecast
6.3.3 Merck - MMRV Pediatric Vaccines Sales and Forecast
6.3.4 Merck - Pneumococcal Pediatric Vaccines Sales and Forecast
6.3.5 Merck - Rotavirus Pediatric Vaccines Sales and Forecast
6.4 Pfizer - Pediatric Vaccines Sales and Forecast (2010 - 2021)
6.4.1 Pfizer - Pneumococcal Pediatric Vaccines Sales and Forecast
6.4.2 Pfizer - Meningococcal Pediatric Vaccines Sales and Forecast
6.5 Novartis - Pediatric Vaccines Sales (2010 - 2014)
6.5.1 Novartis - Influenza Pediatric Vaccines Sales
6.6 bioCSL (Now Seqirus) - Pediatric Vaccines Sales and Forecast (2010 - 2021)
6.6.1 bioCSL - Influenza Pediatric Vaccines Sales and Forecast
6.7 Medimmune (Subsidiary of AstraZeneca) - Pediatric Vaccines Sales and Forecast (2007 - 2021)
6.7.1 Medimmune - Influenza Pediatric Vaccines Sales and Forecast
7. GLOBAL PEDIATRIC VACCINES MARKET - REGIONAL DISTRIBUTION (2010 - 2021)
7.1 United States - Pediatric Vaccines Market and Forecast
7.2 North America/Caribbean - Pediatric Vaccines Market and Forecast
7.3 South America - Pediatric Vaccines Market and Forecast
7.4 Europe - Pediatric Vaccines Market and Forecast
7.5 Japan - Pediatric Vaccines Market and Forecast
7.6 India - Pediatric Vaccines Market and Forecast
7.7 China - Pediatric Vaccines Market and Forecast
7.8 Rest of the World (ROW) - Pediatric Vaccines Market and Forecast
8. MAJOR VACCINES RELATED ACQUISITIONS (2005-2015)
9. PEDIATRIC VACCINES MARKET - DRIVING FACTORS
9.1 GAVI Model Fuelling Vaccine Manufacturers
9.1.1 The Partnership Model
9.1.2 The Business Model
9.2 Global Immunization Vision and Strategy (GIVS)
9.3 Growing Vaccine Availability in United States
9.4 The Vaccine Injury Compensation Program
9.5 The Vaccine Safety Data link Project
9.6 Transformation of Vaccine Technologies
9.7 Global Vaccine Action Plan by WHO (2011 - 2020)
9.8 Continuous Focus on Effective Communication Strategies
10. PEDIATRIC VACCINES MARKET - CHALLENGES
10.1 Hurdles to Optimal use of Licensed Vaccines
10.1.1 Technical Obstacles
10.1.2 Economic obstacles
10.1.3 Cultural Obstacles
10.2 Shortening the Timeline for Vaccine Development
10.3 Complexity of Vaccine Development and Approval System Thwarts Product Development
10.3.1 Legal Obstacles
10.3.2 General Technical Barriers
10.3.3 Economic Barriers
10.3.4 Regulatory Barriers
10.4 Refusal/Resistance to Vaccination
10.5 Vaccine Adverse Event Reporting System
10.6 Vaccine Shortages and Delays
10.7 Obstacles in Vaccine Research and Development
10.8 Barriers to New Entrants in the Vaccines Market
LIST OF FIGURES:
Figure 2-1: Global - Pediatric Vaccines Market (Million US$), 2010 - 2015
Figure 2-2: Global - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
Figure 3-1: Global Pediatric Vaccines - Disease Wise Market Share (Percent), 2010 - 2015
Figure 3-2: Global Pediatric Vaccines - Forecast for Disease Wise Market Share (Percent), 2016 - 2021
Figure 3-3: GlaxoSmithKline (GSK) - Pediatric Vaccines Sales Share (Percent), 2010 - 2015
Figure 3-4: GlaxoSmithKline (GSK) - Forecast for Pediatric Vaccines Sales Share (Percent), 2016 - 2021
Figure 3-5: Sanofi Pasteur - Pediatric Vaccines Sales Share (Percent), 2010 - 2015
Figure 3-6: Sanofi Pasteur - Forecast for Pediatric Vaccines Sales Share (Percent), 2016 - 2021
Figure 3-7: Merck - Pediatric Vaccines Sales Share (Percent), 2007 - 2015
Figure 3-8: Merck - Forecast for Pediatric Vaccines Sales Share (Percent), 2016 - 2021
Figure 3-9: Pfizer - Pediatric Vaccines Sales Share and Forecast (Percent), 2015 - 2021
Figure 3-10: DTaP Pediatric Vaccines - Company Market Share (Percent), 2006 - 2015
Figure 3-11: DTaP Pediatric Vaccines - Forecast for Company Market Share (Percent), 2016 - 2021
Figure 3-12: Hepatitis Pediatric Vaccines - Company Market Share (Percent), 2007 - 2015
Figure 3-13: Hepatitis Pediatric Vaccines - Forecast for Company Market Share (Percent), 2016 - 2021
Figure 3-14: Meningococcal Pediatric Vaccines - Company Market Share (Percent), 2010 - 2015
Figure 3-15: Meningococcal Pediatric Vaccines - Forecast for Company Market Share (Percent), 2016 - 2021
Figure 3-16: Pneumococcal Pediatric Vaccines - Company Market Share (Percent), 2007 - 2015
Figure 3-17: Pneumococcal Pediatric Vaccines - Forecast for Company Market Share (Percent), 2016 - 2021
Figure 3-18: Rotavirus Pediatric Vaccines - Company Market Share (Percent), 2006 - 2015
Figure 3-19: Rotavirus Pediatric Vaccines - Forecast for Company Market Share (Percent), 2016 - 2021
Figure 3-20: Tdap Pediatric Vaccines - Company Market Share (Percent), 2010 - 2015
Figure 3-21: Tdap Pediatric Vaccines - Forecast for Company Market Share (Percent), 2016 - 2021
Figure 3-22: Influenza Pediatric Vaccines - Company Market Share (Percent), 2010 - 2015
Figure 3-23: Influenza Pediatric Vaccines - Forecast for Company Market Share (Percent), 2016 - 2021
Figure 3-24: Region Wise - Pediatric Vaccines Market Share (Percent), 2010 - 2015
Figure 3-25: Region Wise - Forecast for Pediatric Vaccines Market Share (Percent), 2016 - 2021
Figure 4-1: DTaP - Pediatric Vaccines Market (Million US$), 2006 - 2015
Figure 4-2: DTaP - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
Figure 4-3: Polio - Pediatric Vaccines Market (Million US$), 2006 - 2015
Figure 4-4: Polio - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
Figure 4-5: Hepatitis - Pediatric Vaccines Market (Million US$), 2007 - 2015
Figure 4-6: Hepatitis - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
Figure 4-7: Influenza - Pediatric Vaccines Market (Million US$), 2010 - 2015
Figure 4-8: Influenza - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
Figure 4-9: HPV - Pediatric Vaccines Market (Million US$), 2007 - 2015
Figure 4-10: HPV - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
Figure 4-11: Pneumococcal - Pediatric Vaccines Market (Million US$), 2010 - 2015
Figure 4-12: Pneumococcal - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
Figure 4-13: Meningococcal - Pediatric Vaccines Market (Million US$), 2010 - 2015
Figure 4-14: Meningococcal - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
Figure 4-15: MMRV - Pediatric Vaccines Market (Million US$), 2007 - 2015
Figure 4-16: MMRV - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
Figure 4-17: Rotavirus - Pediatric Vaccines Market (Million US$), 2006 - 2015
Figure 4-18: Rotavirus - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
Figure 4-19: Tdap - Pediatric Vaccines Market (Million US$), 2010 - 2015
Figure 4-20: Tdap - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
Figure 5-1: GlaxoSmithKline (GSK) - Pediatric Vaccines Sales (Million US$), 2010 - 2015
Figure 5-2: GlaxoSmithKline (GSK) - Forecast for Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 5-3: Sanofi Pasteur - Pediatric Vaccines Sales (Million US$), 2010 - 2015
Figure 5-4: Sanofi Pasteur - Forecast for Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 5-5: Sanofi Pasteur - Pipeline Vaccines, April 2016
Figure 5-6: Merck - Pediatric Vaccines Sales (Million US$), 2007 - 2015
Figure 5-7: Merck - Forecast for Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 5-8: Novartis - Pediatric Vaccines Sales (Million US$), 2010 - 2014
Figure 5-9: Pfizer - Pediatric Vaccines Sales (Million US$), 2010 - 2015
Figure 5-10: Pfizer - Forecast for Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 5-11: bioCSL - Pediatric Vaccines Sales (Million US$), 2010 - 2015
Figure 5-12: bioCSL - Forecast for Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 5-13: Medimmune - Pediatric Vaccines Sales (Million US$), 2007 - 2015
Figure 5-14: Medimmune - Forecast for Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 6-1: GlaxoSmithKline (GSK) - DTaP Pediatric Vaccines Sales (Million US$), 2010 - 2015
Figure 6-2: GlaxoSmithKline (GSK) - Forecast for DTaP Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 6-3: GlaxoSmithKline (GSK) - Hepatitis Pediatric Vaccines Sales (Million US$), 2010 - 2015
Figure 6-4: GlaxoSmithKline (GSK) - Forecast for Hepatitis Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 6-5: GlaxoSmithKline (GSK) - Meningococcal Pediatric Vaccines Sales (Million US$), 2010 - 2015
Figure 6-6: GlaxoSmithKline (GSK) - Forecast for Meningococcal Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 6-7: GlaxoSmithKline (GSK) - Rotavirus Pediatric Vaccines Sales (Million US$), 2010 - 2015
Figure 6-8: GlaxoSmithKline (GSK) - Forecast for Rotavirus Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 6-9: GlaxoSmithKline (GSK) - Tdap Pediatric Vaccines Sales (Million US$), 2010 - 2015
Figure 6-10: GlaxoSmithKline (GSK) - Forecast for Tdap Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 6-11: GlaxoSmithKline (GSK) - Influenza Pediatric Vaccines Sales (Million US$), 2010 - 2015
Figure 6-12: GlaxoSmithKline (GSK) - Forecast for Influenza Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 6-13: Sanofi Pasteur - DTaP Pediatric Vaccines Sales (Million US$), 2010 - 2015
Figure 6-14: Sanofi Pasteur - Forecast for DTaP Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 6-15: Sanofi Pasteur - Meningococcal Pediatric Vaccines Sales (Million US$), 2010 - 2015
Figure 6-16: Sanofi Pasteur - Forecast for Meningococcal Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 6-17: Sanofi Pasteur - Tdap Pediatric Vaccines Sales (Million US$), 2010 - 2015
Figure 6-18: Sanofi Pasteur - Forecast for Tdap Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 6-19: Sanofi Pasteur - Influenza Pediatric Vaccines Sales (Million US$), 2010 - 2015
Figure 6-20: Sanofi Pasteur - Forecast for Influenza Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 6-21: Merck - Hepatitis Pediatric Vaccines Sales (Million US$), 2007 - 2015
Figure 6-22: Merck - Forecast for Hepatitis Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 6-23: Merck - HPV Pediatric Vaccines Sales (Million US$), 2007 - 2015
Figure 6-24: Merck - Forecast for HPV Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 6-25: Merck - MMRV Pediatric Vaccines Sales (Million US$), 2007 - 2015
Figure 6-26: Merck - Forecast for MMRV Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 6-27: Merck - Pneumococcal Pediatric Vaccines Sales (Million US$), 2007 - 2015
Figure 6-28: Merck - Forecast for Pneumococcal Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 6-29: Merck - Rotavirus Pediatric Vaccines Sales (Million US$), 2007 - 2015
Figure 6-30: Merck - Forecast for Rotavirus Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 6-31: Pfizer - Pneumococcal Pediatric Vaccines Sales (Million US$), 2010 - 2015
Figure 6-32: Pfizer - Forecast for Pneumococcal Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 6-33: Pfizer - Meningococcal Pediatric Vaccines Sales and Forecast (Million US$), 2015 - 2021
Figure 6-34: Novartis - Influenza Pediatric Vaccines Sales (Million US$), 2010 - 2014
Figure 6-35: bioCSL - Influenza Pediatric Vaccines Sales (Million US$), 2010 - 2015
Figure 6-36: bioCSL - Forecast for Influenza Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 6-37: Medimmune - Influenza Pediatric Vaccines Sales (Million US$), 2007 - 2015
Figure 6-38: Medimmune - Forecast for Influenza Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 7-1: United States - Pediatric Vaccines Market (Million US$), 2010 - 2015
Figure 7-2: United States - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
Figure 7-3: North America/Caribbean - Pediatric Vaccines Market (Million US$), 2010 - 2015
Figure 7-4: North America/Caribbean - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
Figure 7-5: South America - Pediatric Vaccines Market (Million US$), 2010 - 2015
Figure 7-6: South America - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
Figure 7-7: Europe - Pediatric Vaccines Market (Million US$), 2010 - 2015
Figure 7-8: Europe - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
Figure 7-9: Japan - Pediatric Vaccines Market (Million US$), 2010 - 2015
Figure 7-10: Japan - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
Figure 7-11: India - Pediatric Vaccines Market (Million US$), 2010 - 2015
Figure 7-12: India - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
Figure 7-13: China - Pediatric Vaccines Market (Million US$), 2010 - 2015
Figure 7-14: China - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
Figure 7-15: ROW - Pediatric Vaccines Market (Million US$), 2010 - 2015
Figure 7-16: ROW - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
Figure 9-1: US - Number of Retail Clinics offering Vaccination (Number), 2007 - 2012
Figure 2-1: Global - Pediatric Vaccines Market (Million US$), 2010 - 2015
Figure 2-2: Global - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
Figure 3-1: Global Pediatric Vaccines - Disease Wise Market Share (Percent), 2010 - 2015
Figure 3-2: Global Pediatric Vaccines - Forecast for Disease Wise Market Share (Percent), 2016 - 2021
Figure 3-3: GlaxoSmithKline (GSK) - Pediatric Vaccines Sales Share (Percent), 2010 - 2015
Figure 3-4: GlaxoSmithKline (GSK) - Forecast for Pediatric Vaccines Sales Share (Percent), 2016 - 2021
Figure 3-5: Sanofi Pasteur - Pediatric Vaccines Sales Share (Percent), 2010 - 2015
Figure 3-6: Sanofi Pasteur - Forecast for Pediatric Vaccines Sales Share (Percent), 2016 - 2021
Figure 3-7: Merck - Pediatric Vaccines Sales Share (Percent), 2007 - 2015
Figure 3-8: Merck - Forecast for Pediatric Vaccines Sales Share (Percent), 2016 - 2021
Figure 3-9: Pfizer - Pediatric Vaccines Sales Share and Forecast (Percent), 2015 - 2021
Figure 3-10: DTaP Pediatric Vaccines - Company Market Share (Percent), 2006 - 2015
Figure 3-11: DTaP Pediatric Vaccines - Forecast for Company Market Share (Percent), 2016 - 2021
Figure 3-12: Hepatitis Pediatric Vaccines - Company Market Share (Percent), 2007 - 2015
Figure 3-13: Hepatitis Pediatric Vaccines - Forecast for Company Market Share (Percent), 2016 - 2021
Figure 3-14: Meningococcal Pediatric Vaccines - Company Market Share (Percent), 2010 - 2015
Figure 3-15: Meningococcal Pediatric Vaccines - Forecast for Company Market Share (Percent), 2016 - 2021
Figure 3-16: Pneumococcal Pediatric Vaccines - Company Market Share (Percent), 2007 - 2015
Figure 3-17: Pneumococcal Pediatric Vaccines - Forecast for Company Market Share (Percent), 2016 - 2021
Figure 3-18: Rotavirus Pediatric Vaccines - Company Market Share (Percent), 2006 - 2015
Figure 3-19: Rotavirus Pediatric Vaccines - Forecast for Company Market Share (Percent), 2016 - 2021
Figure 3-20: Tdap Pediatric Vaccines - Company Market Share (Percent), 2010 - 2015
Figure 3-21: Tdap Pediatric Vaccines - Forecast for Company Market Share (Percent), 2016 - 2021
Figure 3-22: Influenza Pediatric Vaccines - Company Market Share (Percent), 2010 - 2015
Figure 3-23: Influenza Pediatric Vaccines - Forecast for Company Market Share (Percent), 2016 - 2021
Figure 3-24: Region Wise - Pediatric Vaccines Market Share (Percent), 2010 - 2015
Figure 3-25: Region Wise - Forecast for Pediatric Vaccines Market Share (Percent), 2016 - 2021
Figure 4-1: DTaP - Pediatric Vaccines Market (Million US$), 2006 - 2015
Figure 4-2: DTaP - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
Figure 4-3: Polio - Pediatric Vaccines Market (Million US$), 2006 - 2015
Figure 4-4: Polio - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
Figure 4-5: Hepatitis - Pediatric Vaccines Market (Million US$), 2007 - 2015
Figure 4-6: Hepatitis - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
Figure 4-7: Influenza - Pediatric Vaccines Market (Million US$), 2010 - 2015
Figure 4-8: Influenza - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
Figure 4-9: HPV - Pediatric Vaccines Market (Million US$), 2007 - 2015
Figure 4-10: HPV - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
Figure 4-11: Pneumococcal - Pediatric Vaccines Market (Million US$), 2010 - 2015
Figure 4-12: Pneumococcal - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
Figure 4-13: Meningococcal - Pediatric Vaccines Market (Million US$), 2010 - 2015
Figure 4-14: Meningococcal - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
Figure 4-15: MMRV - Pediatric Vaccines Market (Million US$), 2007 - 2015
Figure 4-16: MMRV - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
Figure 4-17: Rotavirus - Pediatric Vaccines Market (Million US$), 2006 - 2015
Figure 4-18: Rotavirus - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
Figure 4-19: Tdap - Pediatric Vaccines Market (Million US$), 2010 - 2015
Figure 4-20: Tdap - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
Figure 5-1: GlaxoSmithKline (GSK) - Pediatric Vaccines Sales (Million US$), 2010 - 2015
Figure 5-2: GlaxoSmithKline (GSK) - Forecast for Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 5-3: Sanofi Pasteur - Pediatric Vaccines Sales (Million US$), 2010 - 2015
Figure 5-4: Sanofi Pasteur - Forecast for Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 5-5: Sanofi Pasteur - Pipeline Vaccines, April 2016
Figure 5-6: Merck - Pediatric Vaccines Sales (Million US$), 2007 - 2015
Figure 5-7: Merck - Forecast for Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 5-8: Novartis - Pediatric Vaccines Sales (Million US$), 2010 - 2014
Figure 5-9: Pfizer - Pediatric Vaccines Sales (Million US$), 2010 - 2015
Figure 5-10: Pfizer - Forecast for Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 5-11: bioCSL - Pediatric Vaccines Sales (Million US$), 2010 - 2015
Figure 5-12: bioCSL - Forecast for Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 5-13: Medimmune - Pediatric Vaccines Sales (Million US$), 2007 - 2015
Figure 5-14: Medimmune - Forecast for Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 6-1: GlaxoSmithKline (GSK) - DTaP Pediatric Vaccines Sales (Million US$), 2010 - 2015
Figure 6-2: GlaxoSmithKline (GSK) - Forecast for DTaP Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 6-3: GlaxoSmithKline (GSK) - Hepatitis Pediatric Vaccines Sales (Million US$), 2010 - 2015
Figure 6-4: GlaxoSmithKline (GSK) - Forecast for Hepatitis Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 6-5: GlaxoSmithKline (GSK) - Meningococcal Pediatric Vaccines Sales (Million US$), 2010 - 2015
Figure 6-6: GlaxoSmithKline (GSK) - Forecast for Meningococcal Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 6-7: GlaxoSmithKline (GSK) - Rotavirus Pediatric Vaccines Sales (Million US$), 2010 - 2015
Figure 6-8: GlaxoSmithKline (GSK) - Forecast for Rotavirus Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 6-9: GlaxoSmithKline (GSK) - Tdap Pediatric Vaccines Sales (Million US$), 2010 - 2015
Figure 6-10: GlaxoSmithKline (GSK) - Forecast for Tdap Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 6-11: GlaxoSmithKline (GSK) - Influenza Pediatric Vaccines Sales (Million US$), 2010 - 2015
Figure 6-12: GlaxoSmithKline (GSK) - Forecast for Influenza Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 6-13: Sanofi Pasteur - DTaP Pediatric Vaccines Sales (Million US$), 2010 - 2015
Figure 6-14: Sanofi Pasteur - Forecast for DTaP Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 6-15: Sanofi Pasteur - Meningococcal Pediatric Vaccines Sales (Million US$), 2010 - 2015
Figure 6-16: Sanofi Pasteur - Forecast for Meningococcal Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 6-17: Sanofi Pasteur - Tdap Pediatric Vaccines Sales (Million US$), 2010 - 2015
Figure 6-18: Sanofi Pasteur - Forecast for Tdap Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 6-19: Sanofi Pasteur - Influenza Pediatric Vaccines Sales (Million US$), 2010 - 2015
Figure 6-20: Sanofi Pasteur - Forecast for Influenza Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 6-21: Merck - Hepatitis Pediatric Vaccines Sales (Million US$), 2007 - 2015
Figure 6-22: Merck - Forecast for Hepatitis Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 6-23: Merck - HPV Pediatric Vaccines Sales (Million US$), 2007 - 2015
Figure 6-24: Merck - Forecast for HPV Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 6-25: Merck - MMRV Pediatric Vaccines Sales (Million US$), 2007 - 2015
Figure 6-26: Merck - Forecast for MMRV Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 6-27: Merck - Pneumococcal Pediatric Vaccines Sales (Million US$), 2007 - 2015
Figure 6-28: Merck - Forecast for Pneumococcal Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 6-29: Merck - Rotavirus Pediatric Vaccines Sales (Million US$), 2007 - 2015
Figure 6-30: Merck - Forecast for Rotavirus Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 6-31: Pfizer - Pneumococcal Pediatric Vaccines Sales (Million US$), 2010 - 2015
Figure 6-32: Pfizer - Forecast for Pneumococcal Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 6-33: Pfizer - Meningococcal Pediatric Vaccines Sales and Forecast (Million US$), 2015 - 2021
Figure 6-34: Novartis - Influenza Pediatric Vaccines Sales (Million US$), 2010 - 2014
Figure 6-35: bioCSL - Influenza Pediatric Vaccines Sales (Million US$), 2010 - 2015
Figure 6-36: bioCSL - Forecast for Influenza Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 6-37: Medimmune - Influenza Pediatric Vaccines Sales (Million US$), 2007 - 2015
Figure 6-38: Medimmune - Forecast for Influenza Pediatric Vaccines Sales (Million US$), 2016 - 2021
Figure 7-1: United States - Pediatric Vaccines Market (Million US$), 2010 - 2015
Figure 7-2: United States - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
Figure 7-3: North America/Caribbean - Pediatric Vaccines Market (Million US$), 2010 - 2015
Figure 7-4: North America/Caribbean - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
Figure 7-5: South America - Pediatric Vaccines Market (Million US$), 2010 - 2015
Figure 7-6: South America - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
Figure 7-7: Europe - Pediatric Vaccines Market (Million US$), 2010 - 2015
Figure 7-8: Europe - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
Figure 7-9: Japan - Pediatric Vaccines Market (Million US$), 2010 - 2015
Figure 7-10: Japan - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
Figure 7-11: India - Pediatric Vaccines Market (Million US$), 2010 - 2015
Figure 7-12: India - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
Figure 7-13: China - Pediatric Vaccines Market (Million US$), 2010 - 2015
Figure 7-14: China - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
Figure 7-15: ROW - Pediatric Vaccines Market (Million US$), 2010 - 2015
Figure 7-16: ROW - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
Figure 9-1: US - Number of Retail Clinics offering Vaccination (Number), 2007 - 2012
LIST OF TABLES:
Table 3-1: Global Pediatric Vaccines - Company Wise Market Share (Percent), 2010 - 2015
Table 3-2: Global Pediatric Vaccines - Forecast for Company Wise Market Share (Percent), 2016 - 2021
Table 8-1: Worldwide - Major Vaccine Related Acquisitions, (2005 - 2015)
Table 9-1: Global - Total Future Deaths Averted through Vaccination (Million), 2011 - 2020
Table 9-2: Global Goal-Level Indicators, 2015 & 2020
Table 9-3: Improvement Strategies or Requirements - the Joint Commission and the Project’s Collaborating Organizations
Table 3-1: Global Pediatric Vaccines - Company Wise Market Share (Percent), 2010 - 2015
Table 3-2: Global Pediatric Vaccines - Forecast for Company Wise Market Share (Percent), 2016 - 2021
Table 8-1: Worldwide - Major Vaccine Related Acquisitions, (2005 - 2015)
Table 9-1: Global - Total Future Deaths Averted through Vaccination (Million), 2011 - 2020
Table 9-2: Global Goal-Level Indicators, 2015 & 2020
Table 9-3: Improvement Strategies or Requirements - the Joint Commission and the Project’s Collaborating Organizations
